Last data update: 24 January 2024 16:39 CET
Plasmid name: pROSA26-DV3 (LMBP 6453)
| New search | Print data sheet |
| Price category: | Cat. 2 (cf. price list) |
| Status: | GeneCorner core plasmid |
| GeneCorner sequence: |
p6453.gb
(View with Genome Compiler) p6453.txt p6453.pdf |
| Sequence analysis results Genecorner: |
|
| Cloned DNA: |
B gene of the control of cell death locus of the Escherichia coli F plasmid (ccdB, lethal gene) Mouse gene trap ROSA 26 gene (Gtrosa26, Gt(ROSA)26Sor, beta geo, Gtrgeo26, R26, ROSA26, Thumpd3as1, GeneID 14910); 5' UTR and 3' UTR |
| Promoter: | Mouse phosphoglycerate kinase 1 promoter (PGK1) Phage T3 promoter Phage T7 gene 10 promoter (T7g10) Escherichia coli lac operon promoter Escherichia coli lac operon promoter; mutant (lacUV5) |
| Ribosome binding site: |
- |
| Terminator: | Bovine growth hormone polyadenylation signal (BGH polyA) |
| Selection marker: | Ampicillin (amp) Chloramphenicol (cam) |
| Replicon: | Escherichia coli plasmid pMB1 origin Phage f1 origin |
| Host range: | Escherichia coli; use a ccdB-resistant strain for propagation (the Invitrogen One Shot ccdB Survival 2 T1R Competent Cells are not recommended for this plasmid) |
| Parental clone: | pBigT-R4-ccdB-CmR-R3; pROSA26-1 |
| Further information: | The plasmid was created by blunt-end cloning the attR4-ccdB-chloramphenicol resistance gene-attR3 cassette from a pBigT-R4-ccdB-CmR-R3 plasmid into the PacI opened and blunted pROSA26-1 vector. pROSA26-DV3 differs from pROSA26-DV2 only in the orientation of the Gateway cassette and the presence of an extra BGH polyA site between the Gateway cassette and the 3' UTR of ROSA26. The plasmid is a multisite Gateway destination vector, containing the ccdB gene inserted between the attenuator sites R4 and R3. Next to this plasmid, three entry clones are needed in the multisite approach to target the gene of interest to the endogeneous ROSA26 locus in mouse ES cells: 1) a 5' entry clone with attL4-R1 sites and containing the chicken β-actin/rabbit β-globin hybrid promoter (AG) and the loxP flanked β-galactosidase-neomycin fusion gene (β-geo) polyA termination cassette (e.g. pEntry attL4pCAGG-loxP-Bgeo-3xpA-loxP-attR1 (LMBP 6455)); 2) a middle entry clone with attL1-L2 sites and containing the gene of interest and 3) a 3' entry clone with attR2-L3 sites and containing the IRES-EGFP reporter (e.g. pEntry attR2-IRES-eGFP-luc+-pA-attL3 (LMBP 8200)). In this approach, a strong, exogeneous promoter is used to drive transgene expression, resulting in higher expression levels as compared to the monosite approach using the endogeneous ROSA26 promoter (see pROSA26-DV1 (LMBP 6451)). Compared to the ROSA26 promoter driven expression, the AG-based expression may become mosaic in various tissues. With pROSA26-DV3, the AG promoter is inserted into the ROSA26 locus in the sense orientation, which may be not as good as the antisense orientation when using pROSA26-DV2 (LMBP 6452), at least in undifferentiated ES cells. The G4 ROSALUC ES cells (LMBP 10507CB) are available at BCCM/GeneCorner as well. Because the risk for recombination after each subcultivation is high, this plasmid is only available under the format of isolated plasmid DNA. The nucleotide sequence of this plasmid corresponds with the EMBL Nucleotide Sequence Database accession number LT726831.1. The depositor suggests that the products of the LR reactions using this vector should be sequenced at their junctions as is outlined in Nyabi et al. (2009) to ensure correct plasmid recombination before final electroporation of the targeting constructs into ES cells. The nucleotide sequence of the attR3 and attR4 regions was analysed at the Department for Molecular Biomedical Research (VIB, Ghent, Belgium). The nucleotide sequence of the 5' and 3' UTR regions of ROSA26 correspond with the EMBL Nucleotide Sequence Database accession number HM588138.1. |
| EMBL Accession number: | HM588138.1, view at EMBL, GenBank, DDBJ LT726831.1, view at EMBL, GenBank, DDBJ |
| Latest sequence update: | 01/08/2013 |
| Authenticity test: | Restriction enzyme pattern analysed at GeneCorner: AvaI/StuI, BglII/EcoRV, NcoI/SmaI, NheI/PvuII and ScaI. This plasmid has also been fully sequenced but the NGS sequence data still need to be implemented. |
| Class: | Recombinant plasmid |
| Type: | Plasmid |
| History of deposit: | This plasmid was deposited by Prof. Dr Jody Haigh(1) (2). (1) Department for Molecular Biomedical Research, VIB, Ghent, Belgium (2) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium |
| Plasmid reference: | Nyabi et al., Nucleic Acids Res. 37 (2009), e55 [PMID: 19279185] [DOI: 10.1093/nar/gkp112] |
| Related plasmid reference: | Movahedi et al., Open Biol 6 (2016), pii 160018 [PMID: 27466441] [DOI: 10.1098/rsob.160018] Mohavedi et al., Biotechnol. Bioeng. - (2018), - [PMID: 29573361] [DOI: 10.1002/bit.26594] Soriano, Nat. Genet. 21 (1999), 70-71 [PMID: 9916792] |
| Restricted distribution: | - VIB/BCCM MTA - When appropriate in accordance with academic customs, RECIPIENT agrees to include the depositor(s) as co-author(s) in the first publication making use of the MATERIAL. |
| Distributed as: | plasmid DNA |
| Host for distribution: | Escherichia coli K12xB DB3.1 |
| Host reference: | - |
| Related host reference: | Bernard et al., J. Mol. Biol. 226 (1992), 735-745 [PMID: 1324324] |
| Cultivation medium: | LB-Lennox + ampicillin (100 μg/ml) + chloramphenicol (34 μg/ml)* |
| Cultivation temperature: | 28°C |
| Biosafety level: | L1 |
| Cultivation remark: | *: selection of transformants on chloramphenicol; subsequent cultivation of a single colony in liquid medium with ampicillin. The plasmid-carrying strain must be cultivated at 28°C instead of 37°C, under heavy shaking, to prevent recombination. After each cultivation, the plasmid has to be checked for recombination. Because of the size of the plasmid, use electro-competent bacterial strains for propagation. |
| Other culture collection numbers: | LMBP 06352 |
Refer in your Materials and Methods: |
pROSA26-DV3 (LMBP 6453) is available at BCCM/GeneCorner. This plasmid was deposited by Prof. Dr Jody Haigh and was published in Nyabi et al., 2009. |
Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.